Beating Wall Street isn't impossible, especially if you stick to time-tested strategies. I focus on wide-moat stocks with strong fundamentals and smart capital allocation. With the rise of low-cost ETFs and passive investing, staying disciplined is more critical than ever. I follow principles that have worked for the best in the game. In my article, I highlight two high-quality businesses I believe can thrive in any environment, growing income, compounding returns, and helping us sleep well at night.

Vancouver, B.C. - TheNewswire - May 7, 2025 – URZ3 Energy Corp. (TSX.V: URZ) (OTCQB: URZEF) (“ URZ3 ” or the “ Company ”) is pleased to announce Mr. Paul Goranson has joined URZ3 as a member of the Board of Directors. Additionally, the Company announces a non-brokered placement of up to $1,100,000. "We are excited to welcome Paul to URZ3 Energy both personally and professionally. The majority of our team have known Mr. Goranson for decades and worked with him in the past. From an industry standpoint, his knowledge of the uranium sector is invaluable including his direct practical …

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Xponential Fitness, Inc. ("Xponential Fitness") (NYSE:XPOF) concerning possible violations of federal securities laws. Xponential issued a press release on March 13, 2025, announcing the Company's fourth quarter and full year financial results.

AUSTIN, Texas , May 7, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended March 31, 2025. Please click the included PDF link to access the full earnings press release.

- End-of-Phase 2 meeting with FDA requested for Alzheimer's disease - - Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC - - Two posters at ARVO describe zervimesine's role supporting retinal cell health - PURCHASE, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, today reported financial results for the first quarter ended March 31, 2025, and provided a business update.

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced it will webcast its 2025 Investor Day beginning at 9:00 a.m. ET on Wednesday, May 21, 2025. The event should conclude at approximately 12:00 p.m. ET. Presentations by Russell A. Becker, President and Chief Executive Officer; David Jackola, Executive Vice President and Chief Financial Officer; and members of APi's senior leadership team will highlight new, meaningfully higher long-ter.

EVERETT, Wash.--(BUSINESS WIRE)--Fortive Corporation ("Fortive") (NYSE: FTV) today announced that James A. Lico, President and Chief Executive Officer, Mark Okerstrom, Senior Vice President and Chief Financial Officer, and Tami Newcombe, President and Chief Executive Officer of Precision Technologies (PT), will be presenting at the BofA Securities Industrials, Transportation & Airlines Key Leaders Conference on Wednesday, May 14th, 2025 at 3:40 p.m. ET (12:40 p.m. PT). The audio will be sim.

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming investor events: BofA Securities 2025 Health Care Conference – May 13-15, 2025 Type: Fireside Chat Presentation Date/Time: May 14, 2025, 11:20 a.m. PDT 2025 RBC Capital Markets Global Healthcare – May 20-21, 2025 Type: Fireside Chat Presentation Date/Time: May 20, 2025, 2:35 p.m. EDT Presentation webcasts may be accessed on the Events an.

SAN FRANCISCO--(BUSINESS WIRE)--Unity (NYSE: U), the leading platform to create and grow games and interactive experiences, today announced financial results for the first quarter ended March 31, 2025. "The Company's first quarter results once again meaningfully exceeded expectations on both revenue and Adjusted EBITDA, highlighting our progress as we continue to build a culture of execution and discipline,” said Matt Bromberg, President and CEO of Unity. “The early success of Unity Vector and.

MUSCATINE, Iowa--(BUSINESS WIRE)--HNI Corporation Reports Earnings for First Quarter Fiscal Year 2025.

NEW YORK--(BUSINESS WIRE)--Payoneer Global Inc. (NASDAQ: PAYO) today reported financial results for its first quarter ended March 31, 2025.

VONORE, Tenn., May 07, 2025 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2025 third quarter ended March 30, 2025.

Separation Creates One of the World's Leading Independent Pure Play Content Companies Lionsgate To Begin Trading Under the Ticker Symbol LION on the NYSE Dual Share Structure Has Been Collapsed into Single Class of Stock SANTA MONICA, Calif., and VANCOUVER, BC , May 7, 2025 /PRNewswire/ -- Lions Gate Entertainment Corp. has completed the full separation of its Studio and STARZ businesses into two standalone, publicly-traded companies.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=147243&wire=1 or contact Joseph E. Levi, Esq.

CrowdStrike will cut hundreds of jobs, as artificial intelligence reshapes the cybersecurity business.

U.S. electric and gas utility NiSource beat Wall Street estimates for first-quarter profit on Wednesday, driven by strong demand for power.

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that test how a treatment works for more than one condition or disease. As researchers uncover the pote.

Revenue rose 15.8% year-over-year, down from 22.0% in Q4. EBITDA growth also decelerated, landing at 36.9% compared to 62.5% the previous quarter. In Q4, Total Reach Campaign usage was up 82%, but that surge hasn't been mirrored in top-line growth - a gap that continued into Q1. That suggests ad yield and efficiency aren't fully dialed in yet. The bull case strengthens if EBITDA margins continue climbing toward (or past) 10%, ARPU keeps growing in the double digits, and Roku begins closing the gap between TRC engagement and monetization.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cerevel-therapeutics-holdings-inc-lawsuit-submission-form?prid=147234&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Universal Display Corporation ("Universal Display Corporation") (NASDAQ:OLED) concerning possible violations of federal securities laws. On October 30, 2024, Universal announced 3Q 2024 revenue results that fell short of consensus and lowered its CY2024 revenue guidance.